Temple officials said the Aetna deal will help the health system expand value-based purchasing programs and quality initiatives.
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WOONSOCKET, R.I., April 24, 2019 /PRNewswire/ -- As part of its commitment to helping build healthier communities, CVS Health (CVS) is reminding Americans to clean out their medicine cabinets and safely dispose of unused medication on National Prescription Drug Take-Back Day, this Saturday, April 27. According to the National Survey on Drug Use and Health, in-home medicine cabinets are often a source of diverted medications, and CVS Pharmacy recommends that patients dispose unused medicines promptly, safely, and securely.
LOS ANGELES / ACCESSWIRE / April 23, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CVS Health Corporation ("CVS" or "the Company") (NYSE: CVS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between May 21, 2015 and February 20, 2019, inclusive (the "Class Period"), are encouraged to contact the firm before April 26, 2019.
NEW YORK, NY / ACCESSWIRE / April 23, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (''CVS'' or the ''Company'') (CVS) and certain of its officers and directors. The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-01725, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired CVS Health securities between May 21, 2015 and February 20, 2019, both dates inclusive (the ''Class Period''), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
WOONSOCKET, R.I., April 23, 2019 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (CVS), announced today that it has completed the rollout of time delay safes in all of its 186 CVS Pharmacy locations in Alabama. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals.